Cardiol Therapeutics (CRDL) Balance Sheet: Assets & Liabilities

Cardiol Therapeutics (CRDL) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2025), Cardiol Therapeutics reported total assets of CAD 23.62M and total liabilities of CAD 5.74M. Shareholders' equity was CAD 17.88M, down 27.7% from CAD 24.73M a year earlier. Total debt stood at CAD 125.52K against CAD 21.42M in cash and short-term investments, a net cash position of CAD 21.29M. That puts debt-to-equity at 0.01, compared with 0.01 a year earlier.

Cardiol Therapeutics Balance Sheet Analysis

Values in millions CAD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cardiol Therapeutics Inc. (CRDL) - Annual data in millions CAD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021	Mar 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	21.42	21.42	30.58	30.58	34.93	34.93	59.47	83.90	14.03	14.03	6.96	16.73	2.36
Cash & Short-Term Investments	21.42	21.42	30.58	30.58	34.93	34.93	59.47	83.90	14.03	14.03	6.96	16.73	2.36
Accounts Receivable	0.23	0.06	0.36	0.10	0.28	0.14	0.21	0.41	0.22	0.22	0.93	0.46	0.10
Inventory	0.00	-	0.00	-	0.00	-	0.00	0.00	0.02	0.36	1.12	6.35	0.00
Other Current Assets	1.86	1.86	0.73	0.73	0.94	0.94	1.49	2.83	0.69	0.35	5.37	6.83	0.03
Total Current Assets	23.50	23.50	31.67	31.67	36.15	36.15	61.44	87.14	14.95	14.95	14.37	24.03	2.48
Non-Current Assets
Property, Plant & Equipment (Net)	0.12	0.12	0.20	0.20	0.34	0.34	0.30	0.36	0.48	0.48	0.58	0.03	0.02
Intangible Assets	0.00	-	0.00	-	0.21	0.21	0.29	0.38	0.46	0.46	0.55	0.63	0.72
Other Non-Current Assets	0.00	-	0.00	-	0.00	-	-	0.00	0.00	-	0.00	0.00	0.00
Total Non-Current Assets	0.12	0.12	0.20	0.20	0.55	0.55	0.59	0.74	0.94	-	1.13	0.66	0.74
Total Assets	23.62	23.62	31.86	31.86	36.70	36.70	62.03	87.88	15.89	15.89	15.50	24.68	3.22
Current Liabilities
Accounts Payable	0.00	3.48	6.98	6.98	0.00	8.04	8.35	4.19	0.00	1.77	0.00	2.14	0.18
Short-Term Debt	0.04	-	0.03	-	0.02	-	0.05	0.04	0.05	-	0.05	0.00	0.00
Accrued Liabilities	-	-	-	-	-	0.42	0.99	0.72	-	0.70	-	-	-
Deferred Revenue	0.00	-	0.00	-	0.00	-	-8.35	-4.19	0.00	-	0.00	0.00	0.00
Other Current Liabilities	5.62	2.14	0.00	-	8.30	0.24	0.42	7.33	2.46	-	0.64	0.00	0.00
Total Current Liabilities	5.66	5.66	7.01	7.01	8.30	8.30	9.80	11.57	2.52	2.52	0.69	2.14	0.18
Non-Current Liabilities
Long-Term Debt	0.09	0.09	0.13	0.13	0.32	0.16	0.02	0.07	0.10	-	0.14	0.27	0.19
Other Non-Current Liabilities	0.00	-	0.00	-	-0.16	-	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Non-Current Liabilities	0.09	0.09	0.13	0.13	0.16	0.16	0.02	0.07	0.10	-	0.14	0.27	0.19
Total Liabilities	5.74	5.74	7.14	7.14	8.45	8.45	9.83	11.64	2.62	2.62	0.83	2.41	0.37
Stockholders' Equity
Common Stock	201.87	201.87	179.34	179.34	148.52	148.52	147.55	142.92	51.92	51.92	39.41	36.72	4.26
Retained Earnings	-213.07	-213.07	-179.25	-179.25	-142.58	-142.58	-114.45	-83.52	-51.88	-51.88	-31.24	-17.55	-1.66
Accumulated Other Comprehensive Income	0.00	-	0.00	-	3.52	3.52	3.52	4.18	4.46	4.46	1.73	-0.01	0.00
Additional Paid-in Capital	29.08	29.08	24.65	24.65	18.79	18.79	15.59	12.66	8.77	-	4.77	1.25	0.00
Shares Outstanding	-	100.26	-	82.61	-	65.35	64.04	61.92	-	-	-	-	-
Total Stockholders' Equity	17.88	17.88	24.73	24.73	28.25	28.25	52.20	76.24	13.27	13.27	14.67	22.27	2.85
Total Liabilities & Equity	23.62	23.62	31.86	31.86	36.70	36.70	62.03	87.88	15.89	-	15.50	24.68	3.22

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cardiol Therapeutics Balance Sheet

How much debt does Cardiol Therapeutics have?

Cardiol Therapeutics had total debt of CAD 125.52K as of Mar 31, 2026, against CAD 21.42M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was CAD 158.53K a year earlier.

What are Cardiol Therapeutics's total assets?

Cardiol Therapeutics reported total assets of CAD 23.62M as of Mar 31, 2026, down 25.9% from CAD 31.86M a year earlier. Total liabilities were CAD 5.74M.

What is Cardiol Therapeutics's shareholders' equity?

Cardiol Therapeutics's shareholders' equity was CAD 17.88M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition